U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 22:49:02 GMT 2025
Edited
by admin
on Mon Mar 31 22:49:02 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
98DE7VN88D
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
mirvetuximab soravtansine [INN]
Preferred Name English
Mirvetuximab Soravtansine
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Immunoglobulin G1-kappa, anti-(human folate receptor alpha (adult folatebending protein, folate receptor 1, KB cells FBP, ovarian tumor-associated antigen Mov18)); humanized mouse monoclonal antibody linked to an average of four molecules of maytansine a
Common Name English
MIRVETUXIMAB SORAVTANSINE [USAN]
Common Name English
IMGN-853
Code English
Immunoglobulin G1, anti-(human folate receptor ?) (human-Mus musculus monoclonal M9346A heavy chain), disulfide with human-Mus musculus monoclonal M9346A light chain, dimer, tetraamide with N2'-[4-[(3-carboxy-3- sulfopropyl)dithio]-4-methyl-1-oxopentyl]-
Common Name English
IMGN853
Code English
Mirvetuximab soravtansine [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 435214
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
FDA ORPHAN DRUG 781620
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL2109414
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
CAS
1453084-37-1
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
DRUG BANK
DB12489
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
FDA UNII
98DE7VN88D
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
EVMPD
SUB181124
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
DAILYMED
98DE7VN88D
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
RXCUI
2621548
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
USAN
BC-78
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
PUBCHEM
91810695
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
SMS_ID
100000166842
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
NCI_THESAURUS
C102566
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
INN
10176
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
ChEMBL
CHEMBL3545132
Created by admin on Mon Mar 31 22:49:02 GMT 2025 , Edited by admin on Mon Mar 31 22:49:02 GMT 2025
PRIMARY
From To
1_22 1_96
1_145 1_201
1_221 3_218
1_227 2_227
1_230 2_230
1_262 1_322
1_368 1_426
2_22 2_96
2_145 2_201
2_221 4_218
2_262 2_322
2_368 2_426
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_298
Related Record Type Details
TARGET->CONJUGATED TOXIN
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION RESIDUE_SPECIFIC K Amount: SORAVTANSINE-LYSINE VIX9T64XBU
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL